The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus

Vaccine

Volumn 23, Issue 39, 2005, Pages 4785-4792

  Yamshchikov, Galina ^a   Borisevich, Victoria ^a   Kwok, Chun Wai ^a   Nistler, Ryan ^a   Kohlmeier, Jake ^a   Seregin, Alexey ^a   Chaporgina, Elena ^a   Benedict, Stephen ^a   Yamshchikov, Vladimir ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Cross reactive; Flaviviridae; Human; Humoral; Neutralizing immune response; Vaccine; West Nile virus

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; YELLOW FEVER VACCINE; GAMMA INTERFERON; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS REACTION; EPIDEMIC ENCEPHALITIS; FEMALE; FLAVIVIRUS; HUMAN; IMMUNIZATION; MALE; PRIORITY JOURNAL; VOLUNTEER; WEST NILE FLAVIVIRUS; YELLOW FEVER; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; SERODIAGNOSIS; T LYMPHOCYTE; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; HUMANS; IMMUNIZATION; INTERFERON TYPE II; JAPANESE ENCEPHALITIS VACCINES; MALE; NEUTRALIZATION TESTS; T-LYMPHOCYTES; WEST NILE FEVER; YELLOW FEVER VACCINE;

EID: 25144508959     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.04.036     Document Type: Article

References (25)

1. Chase M. As virus spreads, views of West Nile grow even darker. Wall Street J 2004(Oct 14);Sect. A:1 (col. 6).
2. Chang GJ, Kuno G, Purdy DE, Davis BS. Recent advancement in flavivirus vaccine development. Expert Rev Vaccines 2004;3:199-220.
3. Pletnev AG, Claire MS, Elkins R, Speicher J, Murphy BR, Chanock RM. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 2003;314:190-5.
4. Lai CJ, Monath TP. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res 2003;61:469-509.
5. Tesh RB, Arroyo J, Travassos Da Rosa AP, Guzman H, Xiao SY, Monath TP. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in Hamster model. Emerg Infect Dis 2002;8:1392-7.
6. Gaunt MW, Sail AA, de Lamballerie X, Falconar AK, Dzhivanian TI, Gould EA. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol 2001;82:1867-76.
7. Barrett AD. Japanese encephalitis and dengue vaccines. Biologicals 1997;25:27-34.
8. Tesh RB, Travassos da Rosa AP, Guzman H, Araujo TP, Xiao SY. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 2002;8:245-51.
9. Williams DT, Daniels PW, Lunt RA, Wang LF, Newberry KM, Mackenzie JS. Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses. Am J Trop Med Hyg 2001;65:379-87.
10. Goverdhan MK, Kulkarni AB, Gupta AK, Tupe CD, Rodrigues JJ. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol 1992;36:277-83.
11. Takasaki T, Yabe S, Nerome R, Ito M, Yamada K, Kurane I. Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice. Vaccine 2003;21:4514-8.
12. Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV. Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 2002;66:115-6.
13. Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, et al. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 1987;161:497-510.
14. Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, Manduca RM, et al. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol 2000;37:208-24.
15. Barrett AD, Mathews JH, Miller BR, Medlen AR, Ledger TN, Roehrig JT. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus. J Gen Virol 1990;71:13-8.
16. Heinz FX, Roggendorf M, Hofmann H, Kunz C, Deinhardt F. Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol 1981;14:141-6.
17. Spector S, Tauraso NM. Yellow fever virus. I. Development and evaluation of a plaque neutralization test. Appl Microbiol 1968;16:1770-5.
18. Fagbami A, Halstead SB, Marchette N, Larsen K. Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians. Am J Trop Med Hyg 1988;38:205-7.
19. Lobigs M, Pavy M, Hall R. Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex. Vaccine 2003;21:1572-9.
20. Spector SL, Tauraso NM. Yellow fever virus II. Factors affecting the plaque neutralization test. Appl Microbiol 1969;18:736-43.
21. Mason RA, Tauraso NM, Spertzel RO, Ginn RK. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Appl Microbiol 1973;25:538-44.
22. Regner M, Lobigs M, Blanden RV, Mullbacher A. Effector cytolotic function but not IFN-gamma production in cytotoxic T cells triggered by virus-infected target cells in vitro. Scand J Immunol 2001;54:366-74.
23. Broom AK, Wallace MJ, Mackenzie JS, Smith DW, Hall RA. Immunisation with gamma globulin to murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against australian encephalitis: evaluation in a mouse model. J Med Virol 2000;61:259-65.
24. Tesh RB, Arroyo J, Travassos Da Rosa AP, Guzman H, Xiao SY, Monath TP. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis 2002;8:1392-7.
25. Niedrig M, Lademann M, Emmerich P, Lafrenz M. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 1999;4:867-71.